Originally published September 15, 2020 During this period I continue to manage risk by swapping out Gilead for United Health Group within my Health Sector group. The main reason for this change is to increase diversification, as all my health sector positions are biopharmas concentrated in drug discovery. At face value, they are all very … Continue reading The Market is Up… Where Next?
Money with Marc 